Page 5 - FLIPBOOK
P. 5
Learning Objectives
By the end of this program, participants will be able to:
• discuss current best practices for first-line treatment of
advanced renal cell carcinoma and options for
subsequent lines of therapy
• review treatment algorithms informing management of
adverse events
• analyze interactive case studies discussion
